Skip to content

FTC approved in the EU for adults and children

Should AZT be excluded from post-exposure prophylaxis?

Triglycerides can normalise after switch from d4T to tenofovir

Do single people progress faster to AIDS and death?

Do CD4 counts rise less on abacavir or nevirapine-based HAART?

Atazanavir begins to lose its clout as protease mutations rise

Combination of indinavir/AZT/3TC still effective for majority of patients at 6 years, says US study

Induction/maintenance approach revived – but will patients stick with it?

Herpes and genital warts most common symptoms of immune reconstitution inflammatory syndrome (IRIS)